DENVER, May 4, 2023 /PRNewswire/ -- DaVita Inc. today published its 2022 Community Care Report, reinforcing its long-standing commitment to corporate citizenship and highlighting meaningful progress made toward meeting the 2025 environmental, social and governance (ESG) goals it set in 2021.
Guided by its Trilogy of Care – Caring for Our Patients, Caring for Each Other and Caring for Our World – DaVita's ambitious, values-based goals are organized across five strategic pillars:
In 2022, DaVita teammates drove initiatives that advanced its goals and held the company accountable to its commitment to better the communities it serves.
"As a Village, we envision a healthier, more vibrant and more equitable world and—more importantly—take action to help create it," says Javier Rodriguez, CEO of DaVita. "This report is a celebration not only of the progress we've made toward our Community Care goals but of our teammates, as our accomplishments are only possible because of their deeply rooted dedication."
Following are key 2022 milestones from each focus area reflected in the report.
Patient Care
Teammate Engagement1
Environmental Stewardship
Caring for Communities
Leading with Integrity & Accountability
To learn more about DaVita's vision for corporate citizenship or to download the full report, visit DaVita.com/CommunityCare.
Media:
Megan Anthony
This email address is being protected from spambots. You need JavaScript enabled to view it.
720-631-2170
About DaVita
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2022, DaVita served 200,000 patients at 2,724 outpatient dialysis centers in the United States. The company also operated 350 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
1 Teammate Engagement section data applies to US teammates as of December 31, 2022.
2 Spencer Stuart 2022 Board Index
Last Trade: | US$146.76 |
Daily Change: | -0.81 -0.55 |
Daily Volume: | 1,026,484 |
Market Cap: | US$12.040B |
October 29, 2024 October 23, 2024 October 17, 2024 September 13, 2024 August 06, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB